Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Rates of thromboembolism and valve thrombosis are higher in patients receiving dual antiplatelet therapy (DAPT; aspirin 325 mg and clopidogrel 75 mg) vs controls in the low-risk arm, according to the results of the Prospective Randomized On-X Anticoagulation Trial (PROACT).
A number of invasive nondental medical procedures appear to significantly increase the risk of infective endocarditis, suggests a recent study.
High-sensitivity cardiac troponin T (hs-cTnT) levels independently predict adverse outcomes in patients with myocardial infarction with nonobstructed coronary arteries (MINOCA), a recent study has shown.
About 10 percent of patients who survive a stroke will likely develop seizures within a decade, with risk factors including haemorrhagic stroke, nonwhite race and younger age, according to a study.
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
In patients with hypertension, awareness of the condition does not appear to influence lifestyle behaviours, according to a recent study.
Having both pre-existing type 2 diabetes (T2D) and chronic kidney disease (CKD) appears to raise the risk of all-cause and cardiovascular disease (CVD)-specific mortality in patients with heart failure, according to results of a Singapore study.
Special Reports
At the recent ‘Reinforced for the Glycaemic Challenge’ symposium held at Shangri-la Hotel, Kuala Lumpur, Associate Professor Dr Alexander Tan, Professor Dr Chee Kok Han and Dr Chan Siew Pheng shared their insights into the importance of achieving glycaemic control in patients with type 2 diabetes mellitus (T2DM), while simultaneously providing them with cardiovascular protection.
CoQ10 isn't as popular as vitamin C or B in our daily lives but it's time to have a closer look at this vital nutrient.
In this issue of MIMS Cardiology Supplement, we bring you clinical updates related to combating hypercholesterolaemia, highlighting the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in lowering low-density lipoprotein-cholesterol levels.
Home blood pressure monitoring (HBPM) is increasingly being recognized as an accurate adjunct to clinic blood pressure measurement for the diagnosis and management of hypertension. We discussed the HOPE Asia Network’s recently published consensus recommendations on HBPM with lead author, Prof. Sungha Park.
Click here to view the interview video with one of the authors - Professor Sungha Park
Click here to view the interview video with one of the authors - Professor Sungha Park
In an effort to better understand hypertension subtypes – including morning and white-coat hypertension – in Asian patients, the HOPE Asia Network has initiated the Asia BP@Home study across 12 countries and regions. We discussed the study’s design and objectives with lead investigator, Prof. Kazuomi Kario.
Click here to view the interview video with lead investigator - Professor Kazuomi Kario
Click here to view the interview video with lead investigator - Professor Kazuomi Kario
At a cardiology conference held in Hilton Kuala Lumpur, senior consultant cardiologist Dato’ Sri Dr Azhari Rosman spoke on the importance of non–high-density lipoprotein cholesterol (non–HDL-C) and combination therapy as a novel approach in the management of atherogenic dyslipidemia (AD).
Through a cardiology webcast hosted by Pfizer, Dr Jeyamalar Rajadurai, Dr Salim Virani and Dr Pamela Morris shared their insights into the importance of primary prevention measures in reducing the burden of atherosclerotic cardiovascular disease (ASCVD).
Conference Reports
The trend of cardiovascular (CV) events among patients with type 2 diabetes (T2D) in Taiwan declined consistently except for myocardial infarction (MI), which had increasing prevalence and incidence rates, according to a 10-year outline of CV disease patterns in T2D presented at APSC 2018.
The use of the sodium/glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin in patients with type 2 diabetes (T2D) and moderate renal impairment provides benefits beyond glucose lowering, with no new safety signals, in the phase III DERIVE* study.
Podcast: Professor Giuseppe Mancia talks about the role of beta-blockers in the overall treatment of hypertension
Slideshow: Highlights from the Asian Pacific Society of Cardiology Congress (APSC) 2018
The appropriate use of sodium/glucose cotransporter 2 inhibitors (SGLT2i) may prevent serious adverse events (SAEs) among Japanese patients with type 2 diabetes (T2D), according to a retrospective analysis of data from medical claim database presented at APSC 2018.
Certain antidiabetic agents (ie, insulin and thiazolidinediones) have been found to be associated with increased cancer risk; however, other studies suggested that metformin may have anticarcinogenic potential, according to a presentation at APSC 2018.
The use of 3D printing prior to transaortic valve replacement (TAVR) procedures may help cardiac surgeons to predict areas where an ill-fitting stent frame could lead to paravalvular leaks (PVLs), a small retrospective study has shown.
Multimedia
